Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. STERIS plc
  6. Summary
    STE   IE00BFY8C754

STERIS PLC

(STE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/11/2021 06/14/2021 06/15/2021 06/16/2021 06/17/2021 Date
198.53(c) 198.37(c) 198.22(c) 198.84(c) 200.28 Last
558 867 1 027 853 718 840 517 478 535 227 Volume
+0.15% -0.08% -0.08% +0.31% +0.72% Change
More quotes
Financials (USD)
Sales 2022 4 517 M - -
Net income 2022 557 M - -
Net Debt 2022 - - -
P/E ratio 2022 35,3x
Yield 2022 0,92%
Sales 2023 4 953 M - -
Net income 2023 738 M - -
Net Debt 2023 - - -
P/E ratio 2023 27,2x
Yield 2023 0,90%
Capitalization 19 819 M 19 819 M -
Capi. / Sales 2022 4,39x
Capi. / Sales 2023 4,00x
Nbr of Employees 13 000
Free-Float 99,6%
More Financials
Company
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (48.1%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions); -... 
More about the company
Ratings of STERIS plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about STERIS PLC
06/09STERISá : 2021 STERIS Annual Report
PU
06/08STERISá : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL DATA (Form 8-K)
PU
06/08STERIS PLCá : Entry into a Material Definitive Agreement, Completion of Acquisit..
AQ
06/02STERIS Completes the Acquisition of Cantel Medical
GL
05/28STERISá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
05/27Crocs to Replace Cantel Medical in S&P MidCap 400, Organogenesis Moves to S&P..
MT
05/27STERIS PLC : Ex-dividend day for
FA
05/26STERISá : Needham Upgrades STERIS to Buy From Hold, Citing Cantel Medical Deal; ..
MT
05/19STERISá : Positioned to Beat FY22 Estimates on Conservative Guidance After Q4 Sh..
MT
05/19STERISá : Poised to see Stable Revenue Growth of 4%-6% in Fiscal 2022, Needham s..
MT
05/18STERISá : Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Ye..
PU
05/18STERISá : Posts Flat Fiscal Q4 Adjusted Earnings; Revenue Gains
MT
05/18STERIS PLCá : Results of Operations and Financial Condition (form 8-K)
AQ
05/18STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Ye..
GL
05/18EARNINGS REACTION HISTORY : STERIS plc, 80.0% Follow-Through Indicator, 3.1% Sen..
MT
More news
News in other languages on STERIS PLC
2019Freudenberg will Hersteller von technischen Textilien übernehmen
More news
Analyst Recommendations on STERIS PLC
More recommendations
Chart STERIS PLC
Duration : Period :
STERIS plc Technical Analysis Chart | STE | IE00BFY8C754 | MarketScreener
Technical analysis trends STERIS PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 220,50 $
Last Close Price 198,84 $
Spread / Highest target 18,2%
Spread / Average Target 10,9%
Spread / Lowest Target -8,97%
EPS Revisions
Managers and Directors
NameTitle
Walter M. Rosebrough President, Chief Executive Officer & Director
Michael Joseph Tokich Chief Financial Officer & Senior Vice President
Mohsen M. Sohi Chairman
Daniel A. Carestio Chief Operating Officer, Director & Senior VP
Kathleen Lynn Bardwell Chief Compliance Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
STERIS PLC4.91%19 819
ABBOTT LABORATORIES0.52%195 557
MEDTRONIC PLC6.73%168 202
BECTON, DICKINSON AND COMPANY-3.97%69 878
HOYA CORPORATION0.11%48 576
ALIGN TECHNOLOGY, INC.12.20%47 450